We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Winners and losers

7 November 2018 By Lisa Jucca

California rejected a plan to cap dialysis rates. A new Congress is also unlikely to curb the cost of U.S. healthcare. Both are good news for the likes of Germany’s Fresenius Medical Care, the world’s top dialysis firm – but less so for insurers and patients.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)